Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- Authors
- Choo, Eun Ju; Chambers, Henry F.
- Issue Date
- Dec-2016
- Publisher
- Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy
- Keywords
- Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment
- Citation
- Infection and Chemotherapy, v.48, no.4, pp 267 - 273
- Pages
- 7
- Journal Title
- Infection and Chemotherapy
- Volume
- 48
- Number
- 4
- Start Page
- 267
- End Page
- 273
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8567
- DOI
- 10.3947/ic.2016.48.4.267
- ISSN
- 2093-2340
2092-6448
- Abstract
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8567)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.